Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.

@article{Linardou2004GemcitabineAC,
  title={Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.},
  author={H. Linardou and G. Aravantinos and E. Efstathiou and C. Kalofonos and A. Anagnostopoulos and C. Deliveliotis and D. Bafaloukos and Meletios Athanasios Dimopoulos and A. Bamias},
  journal={Urology},
  year={2004},
  volume={64 3},
  pages={
          479-84
        }
}
OBJECTIVES To evaluate, in a multicenter Phase II study, the safety and efficacy of the combination of gemcitabine and carboplatin, as first-line treatment in elderly and unfit patients with advanced bladder carcinoma. The toxicity of platinum-based chemotherapy combinations represents a common problem for elderly or unfit patients with advanced bladder carcinoma. METHODS Patients with previously untreated inoperable or metastatic bladder carcinoma and an Eastern Cooperative Oncology Group… Expand
103 Citations
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
  • 47
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.
  • A. Balar, A. Apolo, +8 authors D. Bajorin
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2013
  • 81
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
  • E. Small, D. Lew, +5 authors E. Crawford
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
  • 105
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
  • 81
...
1
2
3
...